Tekla Life Sciences Investors Net Asset Quality Index
Tekla Life Sciences Investors net asset quality index. Tekla Life Sciences Investors (HQL) has a Net Asset Quality Index of 99.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $563.23 Million minus total liabilities of $2.40 Million yields net assets of $560.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Tekla Life Sciences Investors for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Tekla Life Sciences Investors (1996–2025)
Net asset quality index of Tekla Life Sciences Investors from 1996 to 2025. This chart shows how Tekla Life Sciences Investors's Net Asset Quality Index has evolved across 28 annual periods from 1996 to 2025. As of March 2026, the index stands at 99.6%, representing net assets of $560.83 Million against total assets of $563.23 Million USD. Check HQL capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tekla Life Sciences Investors Net Asset Quality Index by Year (1996–2025)
Tekla Life Sciences Investors net asset quality index by year from 1996 to 2025. The table below presents the year-by-year Net Asset Quality Index for Tekla Life Sciences Investors from 1996 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Tekla Life Sciences Investors (HQL) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | $513.66 Million | $515.38 Million | $1.73 Million | ▼ -0.1 pp |
| 2024 | 99.8% | $459.69 Million | $460.58 Million | $888.61K | ▼ 0.0 pp |
| 2023 | 99.8% | $401.93 Million | $402.60 Million | $666.96K | ▲ +3.9 pp |
| 2022 | 95.9% | $397.90 Million | $414.73 Million | $16.82 Million | ▼ -2.0 pp |
| 2021 | 98.0% | $523.44 Million | $534.19 Million | $10.75 Million | ▼ -1.9 pp |
| 2020 | 99.9% | $483.57 Million | $484.17 Million | $595.18K | ▲ +0.6 pp |
| 2019 | 99.3% | $384.16 Million | $386.98 Million | $2.82 Million | ▼ -0.1 pp |
| 2018 | 99.4% | $475.49 Million | $478.47 Million | $2.98 Million | ▼ -0.2 pp |
| 2017 | 99.6% | $466.35 Million | $468.33 Million | $1.98 Million | ▲ +0.2 pp |
| 2016 | 99.4% | $414.97 Million | $417.63 Million | $2.66 Million | ▲ +0.4 pp |
| 2015 | 98.9% | $462.84 Million | $467.85 Million | $5.01 Million | ▼ -0.9 pp |
| 2014 | 99.8% | $444.09 Million | $444.84 Million | $754.55K | ▲ +0.0 pp |
| 2013 | 99.8% | $302.29 Million | $302.82 Million | $530.12K | ▲ +0.0 pp |
| 2012 | 99.8% | $227.08 Million | $227.48 Million | $404.67K | ▲ +0.4 pp |
| 2011 | 99.4% | $170.60 Million | $171.60 Million | $1.00 Million | ▲ +1.5 pp |
| 2010 | 97.9% | $251.40 Million | $256.80 Million | $5.40 Million | ▲ +4.1 pp |
| 2009 | 93.8% | $248.60 Million | $265.10 Million | $16.50 Million | ▼ -5.1 pp |
| 2008 | 98.9% | $277.80 Million | $281.00 Million | $3.20 Million | ▼ -0.8 pp |
| 2007 | 99.6% | $308.00 Million | $309.10 Million | $1.10 Million | ▲ +0.6 pp |
| 2006 | 99.0% | $268.10 Million | $270.80 Million | $2.70 Million | ▼ -0.6 pp |
| 2005 | 99.6% | $229.30 Million | $230.30 Million | $1.00 Million | ▲ +0.2 pp |
| 2004 | 99.3% | $191.80 Million | $193.10 Million | $1.30 Million | ▲ +0.7 pp |
| 2003 | 98.7% | $190.40 Million | $193.00 Million | $2.60 Million | ▼ -1.2 pp |
| 2002 | 99.8% | $157.60 Million | $157.90 Million | $300.00K | ▲ +0.2 pp |
| 2001 | 99.6% | $215.10 Million | $215.90 Million | $800.00K | ▲ +1.0 pp |
| 1998 | 98.6% | $100.00 Million | $101.40 Million | $1.40 Million | ▼ -1.2 pp |
| 1997 | 99.8% | $132.00 Million | $132.20 Million | $200.00K | ▲ +0.3 pp |
| 1996 | 99.5% | $123.10 Million | $123.70 Million | $600.00K | — |